Literature DB >> 3433801

Spectral and kinetic studies of the interaction of imidazole anti-fungal agents with microsomal cytochromes P-450.

A D Rodrigues1, D F Lewis, C Ioannides, D V Parke.   

Abstract

1. The imidazole antifungal agents, ketoconazole, miconazole and clotrimazole have been shown to be potent inhibitors of the phenobarbital-induced cytochromes P-450 and the 3-methylcholanthrene-induced cytochromes P-448-dependent rat hepatic microsomal mixed-function oxidases. 2. All three drugs were more potent inhibitors of the phenobarbital-induced O-deethylation of ethoxycoumarin than of the 3-methylcholanthrene-induced activity indicating selective inhibition of the phenobarbital-induced cytochromes P-450. In both types of microsomes ketoconazole was always the weakest inhibitor. 3. All three compounds elicited type II spectral interactions with both types of microsomes, and had similar Ks values. Miconazole and clotrimazole, and to a lesser extent ketoconazole, also interacted with the substrate binding sites of both phenobarbital-induced cytochromes P-450 and to a lesser extent with the 3-methylcholanthrene-induced cytochrome P-448. 4. It is concluded that at least part of the inhibitory effect of these antifungal agents may reflect competitive inhibition at the substrate binding site.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3433801     DOI: 10.3109/00498258709047162

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  8 in total

1.  Mechanism of the ketoconazole-cyclosporin interaction.

Authors:  E Ah-Sing; T W Poole; C Ioannides; L J King
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

2.  In vivo metabolism of aminopyrine by the larvae of the helminth Heligmosomoides polygyrus.

Authors:  D Kerboeuf; D Soubieux; R Guilluy; J L Brazier; J L Rivière
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

3.  Disposition of azole antifungal agents. I. Nonlinearities in ketoconazole clearance and binding in rat liver.

Authors:  D Matthew; B Brennan; K Zomorodi; J B Houston
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

Review 4.  Safety of acid-suppressing drugs.

Authors:  R A Smallwood; R G Berlin; N Castagnoli; H P Festen; C J Hawkey; S K Lam; M J Langman; P Lundborg; A Parkinson
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

5.  Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir.

Authors:  D J Kempf; K C Marsh; G Kumar; A D Rodrigues; J F Denissen; E McDonald; M J Kukulka; A Hsu; G R Granneman; P A Baroldi; E Sun; D Pizzuti; J J Plattner; D W Norbeck; J M Leonard
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

6.  Ro 09-1470 is a selective inhibitor of P-450 lanosterol C-14 demethylase of fungi.

Authors:  Y Aoki; F Yoshihara; M Kondoh; Y Nakamura; N Nakayama; M Arisawa
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

7.  Identification, modeling and ligand affinity of early deuterostome CYP51s, and functional characterization of recombinant zebrafish sterol 14α-demethylase.

Authors:  Ann Michelle Stanley Morrison; Jared V Goldstone; David C Lamb; Akira Kubota; Benjamin Lemaire; John J Stegeman
Journal:  Biochim Biophys Acta       Date:  2013-12-19

8.  Translational suppression of HIF-1α by miconazole through the mTOR signaling pathway.

Authors:  Jee-Young Park; Hui-Jung Jung; Incheol Seo; Bijay Kumar Jha; Seong-Il Suh; Min-Ho Suh; Won-Ki Baek
Journal:  Cell Oncol (Dordr)       Date:  2014-07-29       Impact factor: 6.730

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.